scispace - formally typeset
Search or ask a question

Which are the statistics for cancer today? 


Best insight from top research papers

Cancer statistics today show that there are approximately 1.7 million new cancer cases and 600,000 cancer deaths projected to occur in the United States in 2019 . The overall cancer incidence rate has remained stable in women but has declined by about 2% per year in men . The cancer death rate has continuously dropped by 27% since 1991, resulting in approximately 2.6 million fewer cancer deaths than expected . However, there are increasing death rates for cancers of the liver, pancreas, and uterine corpus . Cancer is now the leading cause of death in 21 states, primarily due to significant reductions in death from heart disease . Additionally, brain cancer has surpassed leukemia as the leading cause of cancer death in children and adolescents . It is crucial to increase national investment in cancer research and apply existing cancer control knowledge to all segments of the population to accelerate progress against cancer .

Answers from top 5 papers

More filters
Papers (5)Insight
Open accessJournal ArticleDOI
14K Citations
The paper provides statistics for cancer in the United States. In 2018, it is projected that there will be 1,735,350 new cancer cases and 609,640 cancer deaths. The cancer incidence rate has remained stable in women and declined by approximately 2% annually in men. The cancer death rate has declined by about 1.5% annually in both men and women. The overall cancer death rate dropped by 26% from 1991 to 2015. There is a racial disparity in cancer death rates, with non-Hispanic blacks having a higher death rate compared to non-Hispanic whites. The racial disparity is more pronounced in individuals aged <65 years. The racial inequalities in young and middle-aged adults may be due to less access to high-quality healthcare.
Open accessJournal ArticleDOI
16K Citations
The paper provides statistics for cancer in the United States in 2019. It estimates that there will be 1,762,450 new cancer cases and 606,880 cancer deaths in the country.
Book ChapterDOI
01 Jan 2018
9 Citations
The paper provides statistics on cancer globally and in the United States. In 2015, there were 17.5 million cancer cases and 8.7 million deaths worldwide. In the US, it is predicted that there will be 1,688,780 new cases of cancer and 600,920 deaths in 2017.
Open accessJournal ArticleDOI
14.6K Citations
The paper provides statistics for cancer in the United States in 2016, including an estimated 1,685,210 new cancer cases and 595,690 cancer deaths.
The paper provides statistics on cancer, stating that this year there will be 12 million new cancer cases diagnosed and close to 8 million deaths from cancer. It also mentions specific numbers for lung, stomach, liver, colon, and breast cancer deaths.

Related Questions

What was the statistics of breast cancer in 2022?5 answersIn 2022, breast cancer statistics in the United States showed a slow increase in incidence rates by 0.5% annually. Despite this rise, breast cancer mortality rates have been steadily declining, with a 1.3% annual decrease from 2011 to 2020. Racial disparities persist, with Black women experiencing a 40% higher death rate compared to White women. The disparities are particularly pronounced in younger Black women, with a two-fold higher mortality rate than their White counterparts. The progress against breast cancer mortality could be accelerated by addressing these disparities through increased access to high-quality screening and treatment, emphasizing the importance of nationwide Medicaid expansion and collaborative efforts among stakeholders.
Cancer statistics in world 20245 answersIn 2024, the global cancer burden is expected to remain significant, with an estimated increase in new cancer cases and deaths. Worldwide, the most commonly diagnosed cancers include lung, breast, and colorectal cancers, with lung cancer being a major cause of cancer-related deaths. The incidence and mortality rates of various cancers vary across different regions, with stomach and liver cancers being particularly prevalent in Asia, while breast cancer rates are higher in the United States and Europe. Modifiable risk factors such as tobacco use, high body mass index, and lack of physical activity play crucial roles in cancer prevention. International collaboration and efforts to improve cancer control are essential to address the increasing cancer burden globally and reduce cancer-related mortality.
Cancer statistics in the world5 answersIn 2020, there were an estimated 19.3 million new cancer cases globally, with almost 10.0 million cancer-related deaths. Lung cancer was the most commonly diagnosed cancer, followed by female breast, colorectal, prostate, and stomach cancers. Lung cancer also remained the leading cause of cancer death, followed by colorectal, liver, stomach, and female breast cancers. The global cancer burden is projected to rise to 28.4 million cases in 2040, with a significant increase in transitioning countries due to demographic changes and risk factors associated with globalization. In 2018, there were an estimated 18.1 million new cancer cases and 9.6 million cancer deaths worldwide. Lung cancer was the most commonly diagnosed cancer, while female breast cancer was the leading cause of cancer death. High-quality cancer registry data is crucial for effective cancer control programs, especially in low- and middle-income countries.
Cancer statistics of world5 answersCancer is a significant cause of morbidity and mortality worldwide, with an increasing number of cases and deaths over the past decade. In 2020, there were an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths globally. The most commonly diagnosed cancers were female breast, lung, colorectal, prostate, and stomach cancers. Lung cancer remained the leading cause of cancer death, followed by colorectal, liver, stomach, and female breast cancers. The global cancer burden is expected to rise to 28.4 million cases in 2040, with a larger increase in transitioning countries due to demographic changes and increasing risk factors associated with globalization and a growing economy. Efforts to build a sustainable infrastructure for cancer prevention and care in transitioning countries are critical for global cancer control.
What is the statistics of breast cancer in the world?5 answersBreast cancer is the most commonly diagnosed cancer worldwide, with over 2.3 million new cases and 685,000 deaths in 2020. Incidence rates vary across countries and regions, with higher rates in developed countries such as Australia/New Zealand, Northern America, and parts of Europe. Mortality rates are highest in socio-economically low areas, reflecting a lack of access to early screening and timely treatment. Disparities in breast cancer survival exist between developed and less developed regions, with less favorable survival rates in the latter. The burden of breast cancer is predicted to increase to over 3 million new cases and 1 million deaths every year by 2040 due to population growth and aging. Efforts are needed to counteract the growing burden, especially in transitioning countries where incidence is rising rapidly and mortality rates remain high.
What are the current cancer statistics?5 answersIn 2019, it is projected that there will be 1,762,450 new cancer cases and 606,880 cancer deaths in the United States. The cancer incidence rate has remained stable in women but has declined by approximately 2% per year in men over the past decade. The cancer death rate has been declining annually by 1.4% and 1.8% for men and women respectively. Overall, the cancer death rate has dropped by 27% from 1991 to 2016, resulting in approximately 2,629,200 fewer cancer deaths than expected. However, there are still socioeconomic inequalities in cancer mortality, with the most preventable cancers having higher mortality rates in the poorest counties. The progress against cancer can be accelerated by applying existing cancer control knowledge with a focus on disadvantaged groups.

See what other people are reading

What are some background statistics on racial disparities?
5 answers
Racial disparities in various health aspects have been extensively studied. For instance, in papillary thyroid cancer and ER/PR+ breast cancer, white individuals exhibit higher incidence rates compared to black individuals, with overdiagnosis contributing to the observed disparities. In hematologic malignancies, Black patients tend to have lower 5-year relative survival rates compared to White patients, indicating disparities in treatment outcomes. Traumatic brain injury outcomes show no significant racial disparities in neuromonitoring, neurointervention rates, or mortality rates. Postoperative readmission rates after major surgeries like colectomy, hip replacement, and CABG are higher for Black patients, with patient factors and hospital-level differences explaining a significant portion of the disparities. Disparities in sexually transmitted diseases have also been documented, highlighting methodological challenges in quantifying racial/ethnic disparities.
How can changes in breast density be considered in future breast cancer risk stratification?
4 answers
Changes in breast density play a crucial role in future breast cancer risk stratification. Studies have shown that longitudinal changes in mammographic breast density can impact breast cancer risk. An increase in breast density over time is associated with a higher risk of breast cancer, while a continuous decrease in density is linked to a lower risk. Monitoring changes in breast density, especially among high-risk groups like those with benign breast disease, can aid in assessing and managing breast cancer risk. Additionally, understanding the patterns of breast density changes, such as moving between specific density categories, can provide insights into the risk implications and guide risk assessment strategies. Therefore, incorporating assessments of longitudinal breast density changes can enhance risk stratification and potentially lead to more personalized risk reduction strategies for individuals at risk of breast cancer.
What is AGGF1?
7 answers
AGGF1, or Angiogenic Factor with G-patch and FHA domains 1, is a multifaceted protein implicated in various biological processes and diseases. It plays a crucial role in angiogenesis, the growth of new blood vessels, which is essential for healing and regeneration in cardiovascular diseases. AGGF1's significance extends to its therapeutic potential in treating thoracic aortic aneurysm (TAA), where it blocks arterial inflammation and remodeling, highlighting its importance in vascular health. Moreover, AGGF1's involvement in skeletal muscle atrophy underscores its role in muscle health by attenuating muscle atrophy. AGGF1 also has a genetic dimension, with gain-of-function mutations causing Klippel-Trenaunay syndrome, a condition characterized by port-wine stains, varicose veins, and bone and soft tissue hypertrophy. Conversely, somatic loss-of-function mutations in AGGF1 are associated with cancer, indicating its pivotal role in disease pathogenesis. Furthermore, AGGF1 contributes to the neuroprotective effects against postoperative cognitive dysfunction (POCD) in aged rats, showcasing its potential in neuroprotection. At the cellular level, AGGF1 is a key regulatory and structural component of paraspeckles, subnuclear structures involved in gene regulation, where it influences the formation, size, and number of these structures. AGGF1's interaction with endothelial cells through the α5β1 integrin receptor activates signaling pathways crucial for angiogenesis, highlighting its role in vascular development and disease. In cancer research, AGGF1 has been identified as a significant factor in the aggressive progression and poor prognosis of basal-like breast cancer, suggesting its potential as a biomarker and therapeutic target. Additionally, AGGF1's dynamic distribution between the nucleus and cytoplasm in endothelial cells during angiogenesis emphasizes its functional importance in vascular biology. Its role extends to the inflammatory response in human dental pulp cells, where it modulates the synthesis of inflammatory cytokines through the NF-κB signaling pathway and promotes angiogenesis. Lastly, AGGF1, along with NCAPH and FOXC2, has been associated with the clinicopathological characteristics and survival of patients with serous ovarian cancer, further underscoring its relevance in cancer pathology. In summary, AGGF1 is a critical angiogenic factor involved in a wide range of physiological processes and diseases, including vascular health, muscle atrophy, neuroprotection, cancer, and inflammatory responses, making it a potential target for therapeutic intervention across various conditions.
Can the Fuzzy Mamdani model be applied to real-world problems outside of control systems?
5 answers
Yes, the Fuzzy Mamdani model can be effectively applied to real-world problems beyond control systems. Research has shown its successful utilization in various domains such as evaluating teacher performance in online teaching, optimizing cooling systems in water chillers, assessing the performance of urban flood management programs like the Sponge City Programme (SCP), and identifying the risk of breast cancer for individuals. These applications demonstrate the versatility and effectiveness of the Mamdani fuzzy logic model in addressing complex real-world problems outside traditional control systems. By adapting the Mamdani model to different scenarios, researchers have been able to enhance decision-making processes, improve system performance, and provide valuable insights for diverse fields beyond control engineering.
Cancer AND incidence AND worldwide
5 answers
Global cancer burden data reveals that cancer remains a significant health challenge worldwide. In 2020, there were an estimated 19.3 million new cancer cases, with high-income countries (HIC) having the highest incidence rates for various cancers. The most commonly diagnosed cancers globally include female breast, lung, colorectal, prostate, and stomach cancers. Notably, lung cancer is the leading cause of cancer death, with a substantial impact on mortality rates. The incidence of common cancers in males in 2018 included lung, prostate, colorectal, stomach, and liver cancers, with lung cancer being the most prevalent. These findings underscore the ongoing need for effective cancer control measures to address the global burden of cancer and its varying trends across different income settings.
What are the most common coping strategies used by individuals living near polluted sewage?
5 answers
Individuals living near polluted sewage often employ coping strategies to deal with the stress and health risks associated with environmental contamination. Studies show that coping behaviors can vary based on the type of pollution and individual perceptions. For instance, individuals facing haze pollution in Beijing engage in coping behaviors like wearing masks and purchasing air purifiers. On the other hand, women diagnosed with breast cancer in Monteria, Colombia, utilize active coping strategies such as planning, active engagement, and religious practices to navigate the challenges posed by the disease. Environmental contamination can lead to chronic stress, impacting health and quality of life, emphasizing the importance of effective coping mechanisms and community resilience. Overall, understanding and promoting adaptive coping strategies are crucial for individuals living near polluted sewage to mitigate the negative effects of environmental contamination.
Double reading for mammogram in radiologist in Korea
5 answers
Double reading for mammograms by radiologists in Korea has shown to be beneficial in improving cancer detection rates while maintaining low referral rates. Studies have indicated that implementing double reading, where two radiologists independently assess mammograms, can lead to increased sensitivity and recall rates. Furthermore, the use of artificial intelligence as a second reader in a double reading setting has been shown to reduce workload by 44%, increase specificity by 5.3%, and maintain similar sensitivity, suggesting a potential strategy to reduce false positive recalls. Additionally, double reading of tomosynthesis-based mammograms has significantly reduced false-positive interpretations and increased the detection of invasive cancers, demonstrating its effectiveness in improving screening outcomes. Considering these findings, adopting double reading practices for mammograms in Korea could enhance the effectiveness of breast cancer screening programs.
What is the current state of double reading practices for mammograms among radiologists in Korea?
5 answers
The current state of double reading practices for mammograms among radiologists in Korea varies. A study on breast imaging practices in Korea revealed that most radiologists followed the Breast Imaging Reporting and Data System (BI-RADS) for interpreting breast imaging, with a majority performing quality assurance (QA) and evaluating imaging-histologic correlations. Additionally, another study highlighted the extensive use of breast MRI in Korea, with diverse practices among hospitals, including the use of BI-RADS for MRI interpretation and the supervision of MRI by full-time breast radiologists. Furthermore, a study comparing double readings of 2D and 3D mammography found that double reading of tomosynthesis significantly improved cancer detection rates, reducing false-positive interpretations and increasing the detection of invasive cancers.
When is CXCR4 receptor discovered?
5 answers
The CXCR4 receptor was first identified as a chemokine receptor in 1996, marking its discovery as a key co-factor for T-lymphotropic HIV infection and subsequently sparking significant research interest in its role in HIV pathophysiology. CXCR4's importance extends beyond HIV, as it has been found to be a crucial chemokine receptor in the metastasis of various cancers, including breast cancer. Recent studies have highlighted the significance of CXCR4 in physiological and pathological processes, emphasizing its interaction with the chemotactic ligand CXCL12 in cancer progression and metastasis. The continuous exploration of CXCR4's functions has led to the development of potent small molecule inhibitors targeting CXCR4, such as HFX51116, showing promising therapeutic potential in cancer treatment and hematopoietic stem cell mobilization.
Cancer AND incidence AND mortality
5 answers
The burden of cancer, as indicated by both its incidence and mortality rates, is a significant global health concern. Studies show that cancer trends are influenced by socioeconomic factors, with a strong correlation between Human Development Index (HDI) levels and cancer rates. Predictive models are being developed to estimate cancer incidence, especially for less common lethal cancers like brain cancer. The Global Burden of Diseases Study highlights the substantial and growing global burden of cancer, with variations across Sociodemographic Index (SDI) quintiles. Additionally, analyses of "Belt and Road" countries reveal high incidence and mortality rates for common cancers like lung, breast, and colorectal cancers, emphasizing the need for improved prevention and control policies. In the US, cancer remains a leading cause of death, with trends showing declines in mortality rates and variations based on sex and race.
Cancer AND incidence AND mortality AND worldwide
5 answers
Cancer's global burden is substantial, with an estimated 19.3 million new cases and almost 10 million deaths in 2020, excluding nonmelanoma skin cancer. Incidence rates have been rising, with a 44% increase in new cases and a 26% increase in cancer deaths over the past decade. While incidence and mortality rates for most cancers are decreasing in high-income countries, they are increasing in less developed and transitioning countries due to the adoption of unhealthy western lifestyles. The global cancer burden is projected to rise to 28.4 million cases in 2040, with a larger increase in transitioning countries, emphasizing the need for effective prevention measures and cancer care infrastructure in these regions. Efforts to address risk factors associated with globalization are crucial for controlling the escalating cancer rates worldwide.